Farallon Capital Management’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-8,500,000
| Closed | -$394M | – | 120 |
|
|
2019
Q2 | $394M | Buy |
8,500,000
+3,000,000
| +55% | +$139M | 2.56% | 8 |
|
|
2019
Q1 | $134M | Sell |
5,500,000
-250,000
| -4% | -$6.1M | 1.01% | 29 |
|
|
2018
Q4 | $81.9M | Buy |
5,750,000
+625,000
| +12% | +$8.91M | 0.6% | 34 |
|
|
2018
Q3 | $77.9M | Buy |
5,125,000
+475,000
| +10% | +$7.22M | 0.46% | 39 |
|
|
2018
Q2 | $78M | Buy |
4,650,000
+1,555,000
| +50% | +$26.1M | 0.48% | 39 |
|
|
2018
Q1 | $50.5M | Buy |
+3,095,000
| New | +$50.5M | 0.35% | 49 |
|